 |
|
LIVE WEBCAST |
Wednesday, September 19, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Can't make the live webcast? Register now and view it on-demand after the air date. |
|
|
|
Event Overview |
|
Downstream process chromatography scientists are constantly searching for more selective and improved ways to remove aggregates and other process-related impurities from a monoclonal antibody (mAb). Among numerous available separation modes, mixed-mode chromatography is a unique and powerful tool for purifying mAbs. |
|
Hydroxyapatite is a mixed-mode chromatography media that has proven to be useful as a purification medium for biomolecules such as monoclonal antibodies and their aggregates. The highly selective and robust nature of hydroxyapatite can effectively remove dimer and higher order aggregates from a purified mAb sample. Hydroxyapatite has unique separation properties for biomolecules and under optimum conditions offers unparalleled selectivity and resolution for process scale operations. |
|
This presentation reviews the purification of a monoclonal antibody and the removal of its aggregates, showcasing a newly developed method using potassium salts. |
|
Key Learning Objectives
|
• |
Discover a new method for operating hydroxyapatite media for the removal of mAb aggregates to as low as ~1% |
• |
Understand how hydroxyapatite chromatography can provide an effective means of removal of mAb aggregates without jeopardizing the yield or purity of the mAb |
• |
Learn how to select the appropriate conditions to make the most effective use of hydroxyapatite chromatography in mAb and aggregate separations |
|
|
Who Should Attend |
|
Chromatographers, method developers, and process engineers who are involved with the development of downstream purification processes that include steps for aggregate removal |
|
Presenters |
|
 |
 |
Bill Evans |
Process Chromatography Technical Specialist |
Tosoh Bioscience |
|
 |
 |
Kevin O’Donnell, PhD |
Process Chromatography Support Manager |
Tosoh Bioscience |
|
|
 |
 |
Moderator |
Rita Peters |
Editorial Director |
BioPharm International |
|
|
|
|
 |
Sponsored by:
|
|
|
 |
Presented by:
|
|
|
|
|
|
Have any questions? Contact Ethan Castillo at ethan.castillo@ubm.com |
|
|